Am J Transplant, Volume 5, Suppl 3 Archives - Page 75 of 170 - ATC Abstracts

2015 American Transplant Congress
Screening for West Nile Virus in California: Resolving IgM Anti-WNV in the Area With Dengue Seroprevalence
C. Chinchilla-Reyes,^1,2 D. Tanglao,¹ T. Mone,³ M. Koss,¹ M. Nowicki.^1,2
¹Viracor-IBT Laboratories, Los Angeles; ²Mendez National Institute of Transplantation Foundation, Los Angeles; ³OneLegacy, Los Angeles.
West Nile Virus (WNV) symptoms develop 2-15 days after exposure with a short period of viremia (6-7 days). It is possible to detect WNV in…
2015 American Transplant Congress
Long-Term Metabolic Outcomes of Functioning Pancreas Transplants in Type 2 Diabetic Recipients
S. Shin, Y. Kim, B. Choi, J. Choi, J. Jung, H. Cho, D. Han.
Asan Medical Center, Seoul, Korea.
Background Limited data are available on long-term metabolic outcomes of functioning pancreas transplants in patients with type 2 diabetes mellitus (T2DM). The aim of this…
2015 American Transplant Congress
Pediatrics & Donor Derived Disease Transmission: The US OPTN Experience
M. Green,¹ S. Taranto,² S. Covington,² M. Michaels,¹ C. Wolfe,³ D. Kaul.⁴
¹Pediatrics & Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA; ²OPTN/UNOS, Richmond, VA; ³Medicine, Duke University School of Medicine, Durham, NC; ⁴Medicine, University of Michigan School of Medicine, Ann Arbor, MI.
Potential donor derived disease transmission events (PDDTE) are tracked by the OPTN DTAC. Specific evaluation of potential transmissions from pediatric (ped) donors or the impact…
2015 American Transplant Congress
ABO-Incompatible Live Donor Kidney Transplants Inferior to ABO-Compatible Transplants, but Match Deceased Donor Results: Is Kidney Paired Donation the Answer?
J. Verbesey, M. Cooper, A. Gilbert, M. Grafals, P. Weems, J. Moore, S. Ghasemian, C. Nilubol, B. Javaid.
Georgetown University School of Medicine, MedStar Georgetown Transplant Institute, Kidney and Pancreas Transplant Program, Washington, DC.
Objective: Compare kidney allograft survival in ABO-incompatible (ABO-I) and ABO-compatible (ABO-C) live donor kidney transplant recipients.Methods: We analyzed UNOS database for patients who underwent a…
2015 American Transplant Congress
Arterial Blood Pressure at Time of Liver Transplant (LT) Evaluation Correlates With Kidney Biopsy Findings in LT Candidates With Renal Dysfunction
H. Wadei, A. Peguero, A. Alsaad, M. Mai, K. Oshel, T. Gonwa, C. Taner, A. Keaveny.
Transplant, Mayo Clinic, Jacksonville, FL.
Renal dysfunction is common in LT candidates; however, predicting post-LT renal recovery is sometimes difficult. Kidney biopsy is helpful in identifying reversible renal injury but…
2015 American Transplant Congress
Examining Long-Term Survivors in Combined Heart-Lung Transplantation
S. Kadakia,¹ S. Jayarajan,¹ S. Taghavi,¹ V. Ambur,¹ C. Lewis,¹ A. Shiose,² G. Wheatley III,² L. Kaiser,³ T. Guy,² Y. Toyoda.²
¹Department of Surgery, Temple University Hospital, Philadelphia, PA; ²Division of Cardiovascular Surgery, Temple University Hospital, Philadelphia, PA; ³Division of Thoracic Surgery, Temple University Hospital, Philadelphia, PA.
The goal of this study was to determine variables associated with mortality in combined heart-lung transplantation (HLT).The United Network for Organ Sharing (UNOS) database was…
2015 American Transplant Congress
Defining the Epidemiologic Landscape of HIV-Infected Deceased Donors in the United States
A. Cash, A. Shaffer, S. Anjum, A. Massie, D. Segev, C. Durand.
Surgery, Johns Hopkins University, Baltimore, MD.
The HIV Organ Policy Equity Act mandates research on the use of HIV-infected (HIV+) deceased donors (HIVDD) for transplantation in HIV+ recipients. The only data…
2015 American Transplant Congress
Transplanting Pediatric Livers Into Adult Recipients Is Associated With Increased Rejection and Decreased Survival
V. Fleetwood, J. Harris, M. Hertl, E. Chan.
General Surgery, Division of Transplantation, Rush University Medical Center, Chicago, IL.
Introduction: Transplantation of pediatric livers to adult recipients, a measure which places the graft at higher risk of hepatic artery thrombosis (HA), is frequently necessitated…
2015 American Transplant Congress
The Impact of High-Risk Lung Donors on the Survival of Lung Recipients With Interstitial Pulmonary Fibrosis
P. Sanchez,¹ M. Mulligan,¹ C. Evans,¹ I. Timofte,² J. Kim,² K. Rajagopal,¹ A. Iacono,² J. Gammie,¹ R. Pierson III,¹ B. Griffith,¹ S. Pham.¹
¹Cardiac Surgery, University of Maryland School of Medicine, Baltimore, MD; ²Medicine, University of Maryland School of Medicine, Baltimore, MD.
Matching donors and recipients is largely based on experience. With the implementation of the LAS, IPF candidates have the highest provability of being transplanted after…
2015 American Transplant Congress
In Vivo Expansion of Donor-Specific Regulatory T Cells by a New Triazolopyrimidine Derivative and Donor-Specific Transfusion
S. Emoto,¹ R. Goto,¹ S. Shibasaki,¹ A. Nagatsu,¹ H. Ono,¹ R. Igarashi,¹ M. Fukai,² T. Shimamura,³ K. Saiga,⁴ M. Murakami,⁵ A. Taketomi,¹ S. Todo,⁶ K. Yamashita.²
¹Gastroenterological Surgery 1, Hokkaido University, Sapporo, Japan; ²Transplant Surgery, Hokkaido University, Sapporo, Japan; ³Division of Organ Transplantation, Hokkaido University Hospital, Sapporo, Japan; ⁴Nippon Kayaku, Tokyo, Japan; ⁵Institute for Genetic Medecine, Hokkaido University, Sapporo, Japan; ⁶Research Institute, St. Mary Hospital, Kurume, Japan.
Background: We have previously demonstrated that a new triazolopyrimidine derivative, NK026680 (NK) prevents activation/maturation of dendritic cells. This study investigated whether NK together with donor-specific…